Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cato Sept. Same-store Sales Down 3%; Sees Q3 EPS At High End Of Prior Range

RELATED NEWS
Trade CATO now with 

Cato Corp. (CATO) reported that same-store sales for five weeks ended October 5, 2013 decreased 3% from the five weeks ended September 29, 2012. Sales for the five weeks were $72.9 million, a 3% increase over sales of $71.1 million last year.

Sales for the thirty-five weeks ended October 5, 2013 were $628.6 million, down 1% to sales of $637.5 million for the thirty-five weeks ended September 29, 2012. The Company's year-to-date same-store sales decreased 3% from the prior year.

The company now expect third quarter earnings per share will be at the higher end of its guidance range of $0.02 to $0.09 versus $0.16 last year.

Click here to receive FREE breaking news email alerts for Cato Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.